23 July 2009
Mesoblast Limited Is Poised to Take Advantage Of Its Portfolio Of Stem Cell Products And Strategic Assets To Realise Value In FY2010.

27 April 2008
Sunday Herald Sun - Stem Cell Hope for Fixing Injured Knees

February 2008
Asia Pacific Biotech News – Mesoblast One of the Top 10 Leading Biotech Companies in Asia Pacific.

20 February 2008
West Australian - Stem Cells Used to Speed Fracture Repair

24 September 2007
Boning up on mesenchymal stem cells

22 November 2006
The Australian - Wealth

18 June 2006
OzEquities Features Mesoblast

01 June 2006
Transcript ABC-TV CATALYST Program

06 April 2006
National TV coverage of first orthopaedic trial

08 March 2006
Mesoblast national television coverage

08 December 2005
Small but smart – BRW named Mesoblast among 10 stocks that were well placed for 2006

05 September 2005
Mesoblast adult stem cell technology highlighted in inaugural edition of Forbes Asia magazine

03 July 2005
Stem-cell surprise - June 30 - July 6 2005, BRW

03 June 2005
Mesoblast Limited Channel 10 News Transcript

03 June 2005
ABC Radio AM Interview with Professor Silviu Itescu

02 June 2005
Transcript of The (AFL) Footy Show, Melbourne, Channel 9

28 May 2005
Mesoblast a bargain

08 April 2005
ABC Radio National Transcript

12 February 2005
Australia's Top 100 Idols

13 December 2004
THE AUSTRALIAN - STEM CELL RESEARCH BRANCHES OUT

17 December 2004
HERALD SUN - STRONG DEBUT FOR STEM CELL RESEARCHER. MESOBLAST TAKES OFF

THE DAILY TELEGRAPH - STEM CELL FIRM IN DREAM DEBUT


News Room


 

Last Share Price

August 26 2010- Preliminary 2010 Annual Report

August 26 2010 - Mesoblast Financial Year End Results; Strong Clinical Progress, Major Regulatory Milestone and Enhanced Corporate Strategy

23 August 2010 - EGM documents - Letter from the Chairman, Notice of Meeting, Independent Expert Report.

16 August - Mesoblast on track for phase 3 bone marrow transplant trial following positive meeting with FDA

21 July - Mesoblast receives TGA regulatory approval to commercially manufacture adult stem cell products

12 July - Phase 3 meeting scheduled with FDA following positive results of bone marrow regeneration trial

28 May - Mesoblast featured at ASX Singapore conference highlighting emerging market leaders

19 May - United States FDA Clears Phase 2 Trial for Cervical Spinal Fusion

16 August 2010 - Southern Cross Equities research - Phase III getting ready for takeoff

23 July 2010 - Southern Cross Equities Research – Big Pharma will be watching

21 July 2010 - Southern Cross Equities Research – The clinical endgame nears

17 May 2010 - Southern Cross Equities Research – Capitalising the Stem Cell Opportunity

14 May 2010 - Bioshares

26 February - RBS Equities Research - Mesoblast (Buy) 1H10 - Master Blasters

July 2009 - Chairman’s Letter

May 2009 - Chairman’s Letter

May 2008 - Issue Nine